MedPath
FDA Approval

Valganciclovir

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
July 13, 2023
Labeling Type
Human Prescription Drug Label
Valganciclovir(50 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Appco Pharma LLC

078510186

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Appco Pharma LLC

Florida Pharmaceutical Products, LLC

Appco Pharma LLC

078510186

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valganciclovir

Product Details

NDC Product Code
71921-210
Application Number
ANDA216317
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 20, 2023
Code: GCU97FKN3RClass: ACTIBQuantity: 50 mg in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
TARTARIC ACIDInactive
Code: W4888I119HClass: IACT
© Copyright 2025. All Rights Reserved by MedPath